Clinical Trial Update: Risperidone in the Treatment of Psychotic-like and Deficit Symptoms of Schizotypal Personality Disorder [NA]

View source ↗

Summary

Clinical trial update indicates that a study of risperidone for psychotic-like and deficit symptoms in schizotypal personality disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizotypal Personality Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Schizotypal Personality Disorder | NA | Status: COMPLETED